Minimal Invasive Mitral Valve Repair: Late Outcomes

Eyal Ran Nachum Dan Spiegelstein Sergey Preisman Amihai Shinfeld Ehud Raanani
Cardiac Surgery, Chaim Sheba Medical Center, Ramat Gan, Israel

Background

The feasibility and safety of minimally invasive mitral valve (MV) repair using Port-access approach was previously demonstrated. We report our late outcomes of 100 consecutive cases of port-access approach for mitral valve (MV) repair.

Methods

From 2004 to 2014, 894 patients underwent MV repair. From this cohort, 100 patients (11%) underwent minimal invasive MV repair (peripheral cannulation, endo-baloon, thoracoscopic assisted). Mean age was 50±12, and 72 were males (72%).

Results

There was no early death. Operative, bypass and clamp time were 363±56, 139±27 and 97±18 minutes for the first 50 cases and 345±58, 125±23 and 86±19 minutes for the second 50 patients. Mean hospital stay was 5±1 days. Early post-operative echocardiography showed that 3 patients (3%)  had more than grade 2 mitral regurgitation (MR). Major complications included: reopen in 1 patient, TIA in 2(2%) patients and significant kidney injury in 4(4%) patients (non needed dialysis). Follow up was complete, ranged 1-128 months, with mean of 39±33 months, and overall 321 years of patients follow up. At latest follow up 92 (92%) were in NYHA class I or II.

There was 1(1%) late death from unknown reason. Freedom from reoperation due to recurrent MR on the MV was 96%. Late echocardiography revealed that 89(89%) had up to mild MR, 10(10%) moderate and 1(1%) severe MR.

Conclusions

Mitral valve repair with minimal invasive port-access approach is safe and has similar late results to conventional median sternotomy approach.









Powered by Eventact EMS